ArticleAnnals of the New York Academy of Sciences2025
The cost-efficiency of vitamin A supplementation services in Kenya: An assessment of a Malezi Bora event in Kenya.
Article in Annals of the New York Academy of Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Cost and Cost-Effectiveness of Vitamin A Supplementation: An Assessment of a Vitamin A Days-Plus Event in Burkina Faso.Food and nutrition bulletin · 2025Article
- The cost-efficiency of vitamin A supplementation services in Kenya: An assessment of a Malezi Bora event in Kenya.Annals of the New York Academy of Sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Vitamin A supplementation (VAS) remains a cornerstone of global child survival programs. As available funding declines, countries are seeking alternative delivery platforms. We examine a VAS-deworming delivery event in 2019 in Kenya, called Malezi Bora (MB), that employed four delivery platforms: health clinics, Early Childhood Development centers, community distribution points, and home visits. VAS coverage data were collected via household surveys in four subcounties, three of which received financial and technical assistance, and one of which received technical assistance only. Data on costs were collected using structured and semi-structured questionnaires. Only one subcounty achieved the targeted VAS coverage rate (80%) across most age subgroups; the subcounty not receiving financial assistance covered just 37% of children 6-59 months of age. Two other funded subcounties had higher coverage rates but failed to achieve 80% coverage for any age subgroup. Most children in the funded subcounties received VAS in their homes. Most children in the unfunded subcounty received VAS at a health facility. Being aware of MB was the most important factor associated with receiving VAS. Cost per child reached, including opportunity costs, varied across subcounties from $1.81 to $11.13 USD. Salaries were the main cost drivers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.